China Pharma Holdings, Inc. (CPHI) Financial Statements (2024 and earlier)

Company Profile

Business Address 2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, 570216
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,0304,8599581,0751,1872,030
Cash and cash equivalents2,0304,8599581,0751,1872,030
Receivables  5026359172,253
Inventory, net of allowances, customer advances and progress billings2,9483,3403,7053,5895,0556,407
Inventory2,9483,3403,7053,5895,0556,407
Prepaid expense78597477124186
Other undisclosed current assets909836842031,4651,414
Total current assets:5,9659,0935,3225,5798,74712,290
Noncurrent Assets
Operating lease, right-of-use asset3912850137
Property, plant and equipment9,97313,28115,56416,31419,29423,541
Intangible assets, net (including goodwill)1,807148182206266399
Intangible assets, net (excluding goodwill)1,807148182206266399
Other undisclosed noncurrent assets     17,07023,723
Total noncurrent assets:11,82013,55615,79616,65636,63047,663
TOTAL ASSETS:17,78422,65021,11822,23545,37759,953
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,4628424,1605,1174,4374,276
Accounts payable3,0572,8113,9834,9274,1264,000
Accrued liabilities405298177190311276
Other undisclosed accounts payable and accrued liabilities (2,268)    
Deferred revenue520210720 
Debt6,2414,3294,3372,2412,1812,305
Due to related parties 2,070 2,0721,6331,355
Customer advances and deposits581
Other liabilities 2,4762,7802,134   
Other undisclosed current liabilities40283526151,800710
Total current liabilities:12,73910,51311,40410,04510,0519,227
Noncurrent Liabilities
Long-term debt and lease obligation 5,2949042,1994,3636,916
Long-term debt, excluding current maturities 5,2509042,1504,3636,916
Liabilities, other than long-term debt755824806 764738
Deferred tax liabilities, net764738
Deferred income tax liabilities755824806 
Operating lease, liability 44 49
Other undisclosed noncurrent liabilities    753  
Total noncurrent liabilities:7556,1191,7102,9525,1277,654
Total liabilities:13,49416,63213,11312,99815,17916,882
Equity
Equity, attributable to parent4,2906,0188,0059,23830,19943,071
Common stock754746444444
Additional paid in capital28,85425,64524,45323,59023,59023,590
Accumulated other comprehensive income11,57312,56412,34511,57611,83513,958
Retained earnings (accumulated deficit)(36,211)(32,239)(28,839)(25,972)(5,270)5,480
Total equity:4,2906,0188,0059,23830,19943,071
TOTAL LIABILITIES AND EQUITY:17,78422,65021,11822,23545,37759,953

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues8,1049,64210,86610,92412,33113,212
Cost of revenue(8,598)(9,293)(8,914)(9,442)(10,356)(10,744)
Gross profit:(494)3491,9531,4821,9752,469
Operating expenses(3,055)(3,210)(4,531)(21,890)(12,422)(21,149)
Operating loss:(3,549)(2,861)(2,578)(20,408)(10,447)(18,680)
Nonoperating expense(424)(539)(288)(294)(413)(475)
Interest and debt expense(250)(280)(294)(322)(451)(539)
Loss from continuing operations before equity method investments, income taxes:(4,223)(3,679)(3,161)(21,024)(11,311)(19,694)
Other undisclosed income from continuing operations before income taxes250280294322451539
Loss from continuing operations before income taxes:(3,973)(3,399)(2,867)(20,702)(10,860)(19,155)
Income tax expense (benefit)     110(123)
Loss from continuing operations:(3,973)(3,399)(2,867)(20,702)(10,750)(19,278)
Loss before gain (loss) on sale of properties:(3,399)(2,867)(20,702)(10,750)(19,278)
Net loss available to common stockholders, basic:(3,973)(3,399)(2,867)(20,702)(10,750)(19,278)
Other undisclosed net loss available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(3,973)(3,399)(2,867)(20,702)(10,750)(19,278)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(3,973)(3,399)(2,867)(20,702)(10,750)(19,278)
Other comprehensive loss      (15,838)
Comprehensive loss:(3,973)(3,399)(2,867)(20,702)(10,750)(35,115)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(991)218769(259)(2,122) 
Comprehensive loss, net of tax, attributable to parent:(4,964)(3,181)(2,098)(20,961)(12,873)(35,115)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: